Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection

被引:90
作者
Huigen, MCDG
Kamp, W
Nottet, HSLM
机构
[1] Eijkman Winkler Ctr Microbiol Infect Dis & Inflam, Utrecht, Netherlands
[2] Fight Life Fdn, Amsterdam, Netherlands
关键词
acquired immunodeficiency syndrome; gene expression; HIV-1 trans-activator (Tat) protein; human immunodeficiency virus type 1 (HIV-1); immune regulation;
D O I
10.1111/j.1365-2362.2004.01282.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The HIV-1 trans-activator (Tat) protein is proposed as an important factor in the complex HIV-induced pathogenesis of AIDS. In this paper, multiple effects of this viral protein are described. Originally discovered as an intracellular activator of HIV-1 transcription, Tat was found to regulate viral reverse transcription as well. Trans-activator was found to be secreted by HIV-infected cells and taken up by neighbouring cells. In this way, Tat is able to affect both infected and uninfected cells. Intracellularly, Tat can deregulate the expression of several heterologous cellular and viral genes. Extracellular Tat can contribute to the spreading of HIV-1 and immunosuppression of uninfected cells. Finally, there is evidence that exogenous Tat is involved in AIDS-associated pathologies such as Kaposi's sarcoma and HIV-associated dementia. These capacities together accelerate the progression towards AIDS and make Tat an interesting candidate as a constituent of an anti-AIDS vaccine.
引用
收藏
页码:57 / 66
页数:10
相关论文
共 113 条
[1]   ANGIOGENIC PROPERTIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN [J].
ALBINI, A ;
BARILLARI, G ;
BENELLI, R ;
GALLO, RC ;
ENSOLI, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4838-4842
[2]   HIV-1 Tat protein mimicry of chemokines [J].
Albini, A ;
Ferrini, S ;
Benelli, R ;
Sforzini, S ;
Giunciuglio, D ;
Aluigi, MG ;
Proudfoot, AEI ;
Alouani, S ;
Wells, TNC ;
Mariani, G ;
Rabin, RL ;
Farber, JM ;
Noonan, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (22) :13153-13158
[3]   The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells [J].
Albini, A ;
Soldi, R ;
Giunciuglio, D ;
Giraudo, E ;
Benelli, R ;
Primo, L ;
Noonan, D ;
Salio, M ;
Camussi, G ;
Rockl, W ;
Bussolino, F .
NATURE MEDICINE, 1996, 2 (12) :1371-1375
[4]   Identification of a novel domain of HIV Tat involved in monocyte chemotaxis [J].
Albini, A ;
Benelli, R ;
Giunciuglio, D ;
Cai, T ;
Mariani, G ;
Ferrini, S ;
Noonan, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (26) :15895-15900
[5]   HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors [J].
Ambrosino, C ;
Ruocco, MR ;
Chen, XN ;
Mallardo, M ;
Baudi, F ;
Trematerra, S ;
Quinto, I ;
Venuta, S ;
Scala, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) :14883-14892
[6]   Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: Implication of protein kinase C-dependent pathway [J].
Badou, A ;
Bennasser, Y ;
Moreau, M ;
Leclerc, C ;
Benkirane, M ;
Bahraoui, E .
JOURNAL OF VIROLOGY, 2000, 74 (22) :10551-10562
[7]   THE TAT PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, A GROWTH-FACTOR FOR AIDS KAPOSI-SARCOMA AND CYTOKINE-ACTIVATED VASCULAR CELLS, INDUCES ADHESION OF THE SAME CELL-TYPES BY USING INTEGRIN RECEPTORS RECOGNIZING THE RGD AMINO-ACID-SEQUENCE [J].
BARILLARI, G ;
GENDELMAN, R ;
GALLO, RC ;
ENSOLI, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :7941-7945
[8]   HIV as the cause of AIDS [J].
BarreSinoussi, F .
LANCET, 1996, 348 (9019) :31-35
[9]   STRUCTURAL STUDIES OF HIV-1 TAT PROTEIN [J].
BAYER, P ;
KRAFT, M ;
EJCHART, A ;
WESTENDORP, M ;
FRANK, R ;
ROSCH, P .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 247 (04) :529-535
[10]   The neglected role of type I interferon in the T-cell response: Implications for its clinical use [J].
Belardelli, F ;
Gresser, I .
IMMUNOLOGY TODAY, 1996, 17 (08) :369-372